Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. KLRS
KLRS logo

KLRS News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

KLRS News

Kalaris Therapeutics Reports Q1 Financial Results

May 12 2026seekingalpha

Kalaris Therapeutics Reports FY GAAP EPS of -$2.85

Mar 17 2026seekingalpha

Kalaris Gains Momentum with Promising Initial Results from Neovascular AMD Trial and $50 Million Financing Support

Dec 18 2025NASDAQ.COM

Kalaris Therapeutics Secures $50 Million in Private Placement Financing

Dec 17 2025Globenewswire

Kalaris Therapeutics Secures $50 Million in Private Placement Financing

Dec 17 2025Newsfilter

Kalaris TH103 Shows Significant Visual Improvement in Initial Clinical Trial Data

Dec 17 2025Newsfilter

Monday's Underperforming Sectors: Biotechnology, Electronic Equipment, and Products

Dec 01 2025NASDAQ.COM

Kalaris Enhances Leadership by Appointing Matthew Gall, MBA, as CFO

Nov 03 2025Newsfilter

KLRS Events

No data

No data

KLRS Monitor News

No data

No data

KLRS Earnings Analysis

No Data

No Data

People Also Watch